SCHEMBL574287

SCHEMBL574287

CCC(C)COC(=O)CC(C)C

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
PRKCA P17252 2/20 0.42
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
MMP13 P45452 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
ALDH1A1 P00352 1/20 0.37
RECQL P46063 1/20 0.36
ELANE P08246 1/20 0.36
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
ATM Q13315 1/20 0.35
ALOX15 P16050 1/20 0.35
FFAR1 O14842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5907693 0.85 MAPT (0.43) MAPTPRKCATDP1RECQLELANE
SCHEMBL18856309 0.83 PRKCA (0.41) MAPTPRKCAMMP1MMP2MMP3
SCHEMBL9744311 0.83 MAPT (0.42) MAPTPRKCATDP1RECQLELANE
SCHEMBL21474533 0.83 MAPT (0.39) MAPTPRKCATDP1ALDH1A1RECQL
SCHEMBL30547120 0.83 TDP1 (0.47) MAPTPRKCAMMP1MMP2MMP3
SCHEMBL5033123 0.83 PRKCA (0.42) PRKCAMMP1MMP2MMP3MMP9
SCHEMBL5859548 0.82 MGAM (0.50) MAPTPRKCATDP1ALDH1A1ELANE
SCHEMBL30320231 0.82 MAPT (0.47) MAPTTDP1ALDH1A1ELANECYP3A4
SCHEMBL2854978 0.82 MAPT (0.47) MAPTTDP1ALDH1A1ELANECYP3A4
SCHEMBL14672451 0.82 MAPT (0.47) MAPTPRKCATDP1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260096574-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2026-04-09 US claimed
US-20260007144-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2026-01-08 US claimed
EP-4606226-A2 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. (US) 2025-08-27 EP claimed
EP-4578292-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. (US) 2025-07-02 EP claimed
CN-119799505-A Natural geotrichum candidum (Geotrichum candidum) and application thereof 蘑米(广州)生物科技有限公司 2025-04-11 CN claimed
US-20250072446-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. 2025-03-06 US claimed
US-20250017954-A1 Formulations and Methods for Treating Symptoms of Menopause Kindra Corporation (US) 2025-01-16 US claimed
US-20250008978-A1 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. 2025-01-09 US claimed
EP-4255208-B1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-12-25 EP claimed
EP-4470389-A2 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. (US) 2024-12-04 EP claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
EP-1716159-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS General Electronic Company (US) 2006-11-02 EP claimed
EP-1697386-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES General Electric Company A Corporation of the State of New York (US) 2006-09-06 EP claimed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US claimed
CN-1674862-A Perfume composition KAO CORP (JP) 2005-09-28 CN claimed
WO-2005066187-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
WO-2005066186-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP claimed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260007144-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS HAAO, PTGES2, PTGES MAPT 3127/4885PRKCA 3826/4885MMP1 2512/4885
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients F9, RPL39, ECPAS MAPT 815/4885PRKCA 3726/4885MMP1 541/4885
US-20050136021-A1 Active-releasing cyclic siloxanes F9, RPL39, ALDH16A1 MAPT 1453/4885PRKCA 3688/4885MMP1 198/4885
US-20260096574-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS HAAO, HTR6, SCD MAPT 1434/4885PRKCA 2946/4885MMP1 4488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.